Slingshot members are tracking this event:

DBV Tech (DBVT) Completes Enrollment for Phase 2b MILES Study Evaluating Viaskin Milk for Patients Ages 2-17 with IgE-mediated Cow's Milk Protein Allergy (CMPA)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 08, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Enrollment, Phase 2b, Miles, Viaskin Milk, Ige-mediated, Cow's Milk Protein Allergy, Cmpa